The Management of Systemic-Pulmonary Collateral Blood Flow in Cyanotic Children During Cardiopulmonary Bypass

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether it is possible to manage the flow of blood through blood vessels using varying levels of carbon dioxide during cardiac surgery, and what effect this has on how well the major organs of the body work.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Maternal Hyperoxygenation in Congenital Heart Disease

NCT03136835

Hypoplastic Left Heart Syndrome

COMPLETED PHASE1/PHASE2

NO During CPB in Neonates to Reduce Risk of AKI

NCT04216927

AKI CHD - Congenital Heart Disease Surgery

RECRUITING PHASE3

Nitric Oxide During CPB to Reduce AKI in Neonates

NCT03946462

Congenital Heart Disease Acute Kidney Injury

WITHDRAWN PHASE1

Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass

NCT03576534

Congenital Heart Disease

TERMINATED NA

Aprotinin in Neonates Undergoing Cardiopulmonary Bypass

NCT00469742

Cardiopulmonary Bypass Congenital Defects Hemostasis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A great number of studies have shown that MAPCAs are a real issue for these patients, who require far higher blood flows than previously suggested. However, the optimal method of CPB is still unknown. Recent research by Sakamoto et al., showed that a raised carbon dioxide (pCO2) increased brain blood flow in cyanotic patients, suggesting a noticeable decrease in aorto-pulmonary blood shunting. However, the mechanism of this action is not understood and it is unclear if this observation is an associated or causative one. Whilst the vasoconstrictive (narrowing of vessels) effect of hypoxia has been well documented, with and without high carbon dioxide, there are no reports indicating that pCO2 alone increases the narrowing of blood vessels in the lung. We hypothesize that a rise in pCO2 could cause a shift in blood flow from pulmonary to systemic circulation, either through direct constricting action on MAPCA vessels, or through a vasoconstriction of blood vessels in the lung. Furthermore, we predict the phenomenon could potentially be used to optimize the method of treatment, ensuring that vital organs receive the correct amount of blood flow during the surgical correction of these rare congenital heart diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Defects, Congenital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alpha Stat

Standard CPB blood gas management conditions

Group Type NO_INTERVENTION

No interventions assigned to this group

pH Stat

pH stat blood gas management conditions.

Group Type EXPERIMENTAL

pH Stat

Intervention Type DRUG

pH stat blood gas management - increased carbon dioxide content of administered gas mixture.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pH Stat

pH stat blood gas management - increased carbon dioxide content of administered gas mixture.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients whose parents/guardians are willing and able to provide written informed consent for participation in the study
* Patients undergoing elective TCPC surgery
* MRI proven presence of MAPCA vessels
* Patients between 1 day and 5 years of age

Exclusion Criteria

* Emergency surgery
* Documented history of cognitive impairment (may have an effect on biochemical markers of cerebral injury)
* Documented history of major organ dysfunction

Minimum Eligible Age

1 Day

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No